US2010298684A1PendingUtilityA1
Analyte sensor
Est. expiryOct 4, 2026(~0.2 yrs left)· nominal 20-yr term from priority
Inventors:Jacob S. LeachMark C. BristerSean SaintJames R. PetisceMark C. ShultsDavid K. WongKum Ming Woo
A61M 5/14A61B 5/6849A61B 5/14546A61M 5/16804A61B 5/1495A61M 5/1723A61B 5/412A61B 5/14865A61B 5/14532A61B 5/6848A61B 5/14542A61B 2560/0223A61B 5/1473A61M 2230/201
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Claims
exact text as granted — not AI-modified1 . A system for measuring an analyte, the system comprising:
a vascular access device configured to be in communication with a circulatory system of a host; an analyte sensor configured to reside within the vascular access device, wherein the analyte sensor is configured to measure a concentration of an analyte within the circulatory system; and a flow control device configured to draw blood into the vascular access device at a first flow rate of from about 0.001 ml/min to about 0.2 ml/min, wherein the flow control device is further configured to pass an infusion solution through the vascular access device at a second flow rate, wherein the first flow rate is not equal to the second flow rate.
2 . The system of claim 1 , wherein the analyte is glucose.
3 . The system of claim 1 , wherein the vascular access device comprises a catheter, and wherein the sensor is located within the catheter.
4 . The system of claim 3 , wherein the catheter is 21 gauge or smaller.
5 . The system of claim 1 , wherein the vascular access device comprises a catheter and a fluid coupler connectable to the catheter.
6 . The system of claim 1 , wherein the vascular access device comprises at least one of a venous catheter or an arterial catheter.
7 . The system of claim 1 , wherein the vascular access device comprises a Swann Gantz catheter.
8 . The system of claim 1 , wherein the vascular access device comprises a multi-lumen catheter, and wherein the sensor is located in one of the catheter's lumens.
9 . The system of claim 1 , wherein the first flow rate is configured to substantially block mixing of the infusion solution and the sample.
10 . The system of claim 1 , wherein the second flow rate is from about 0.001 ml/min to about 2 ml/min.
11 . The system of claim 10 , wherein the second flow rate is from about 0.02 ml/min to about 0.35 ml/min.
12 . The system of claim 10 , wherein the second flow rate is configured to allow a temperature of the infusion solution to substantially equilibrate with a temperature of the host.
13 . A system for measuring an analyte, the system comprising:
a vascular access device configured to be in communication with a circulatory system of a host; an analyte sensor configured to reside within the vascular access device, wherein the analyte sensor is configured to measure a concentration of an analyte within the circulatory system; and a valve comprising a first position and a second position that is different from the first position, wherein the system is configured such that about 150 microliters or less of a fluid passes through the vascular access device during movement of the valve at a predetermined rate between the first position and the second position during a predetermined amount of time.
14 . The system of claim 12 , wherein the system is configured to push fluid through the vascular access device during movement of the valve from the first position to the second position.
15 . The system of claim 12 , wherein the valve is configured such that about 50 microliters or less of a fluid passes through the vascular access device during the movement of the valve between the first position and the second position.Join the waitlist — get patent alerts
Track US2010298684A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.